|Articles|October 1, 2014
- BioPharm International-10-01-2014
- Volume 27
- Issue 10
BioPharm International, October 2014 Issue (PDF)
Click the title above to open the BioPharm International October 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 11 years ago
Bolstering Graduate Education and Research Programsover 11 years ago
Continued Process Verification for Biopharma Manufacturingover 11 years ago
Disposable Filtration Device Improves Bioburden Testingover 11 years ago
CMO Industry Thins Outover 11 years ago
Challenges in Biologic Drug and Vaccine Deliveryover 11 years ago
Continuous Improvement in Biopharma Manufacturingover 11 years ago
Application of Quality by Design to Viral Safetyover 11 years ago
Biopharma Manufacturers Respond to Ebola Crisisover 11 years ago
Coupling Light Scattering with Size-Exclusion ChromatographyNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5
